Innovation in pharma sector: The impact of ipr (product patent) in Indian scenario: an overview
The Indian Pharmaceutical Industries underwent phenomenal change after 1 January 2005, when international patent laws were implemented. India’s domestic pharmaceutical companies have experienced a significant increase in R and D spending to be competitive in the world market. Although the Indian pharmaceutical market is very small and does not have enough funding for drug discovery programs, India has well-educated scientists, a well-established computer industry, and technological know-how for the manufacture of bulk drugs and formulations.